Products
19065 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 6.015 | 2.07 | 0.010 | 2.08 | 1 | -10.78% | -41.69% | 218.46% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 6.015 | 135.92 | 1.330 | 137.25 | 1 | -21.16% | -70.19% | 510.05% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 6.015 | 0.072 | 0.001 | 0.073 | 1 | 5.88% | 22.03% | -93.51% | 30 Nov. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 6.015 | 0.055 | 0.001 | 0.056 | 1 | 10.00% | 37.50% | -98.48% | 21 Aug. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 99.995 | 8.9 | 0.060 | 8.96 | 1 | -1.00% | 18.51% | -59.45% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 99.995 | 9.2 | 0.030 | 9.23 | 1 | -0.54% | 5.38% | -21.30% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 99.995 | 0.62 | 0.010 | 0.63 | 1 | -3.13% | 12.73% | -50.40% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 99.995 | 5.46 | 0.020 | 5.48 | 1 | -0.55% | 8.33% | -31.41% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 99.995 | 2.27 | 0.010 | 2.28 | 1 | -0.87% | 11.82% | -41.04% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 99.995 | 0.61 | 0.010 | 0.62 | 1 | -3.17% | -10.29% | 22.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 99.995 | 2.02 | 0.010 | 2.03 | 1 | -1.46% | -6.48% | 16.76% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 99.995 | 0.8 | 0.010 | 0.81 | 1 | -2.44% | -17.53% | 45.45% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 99.995 | 0.15 | 0.010 | 0.16 | 1 | -11.76% | -16.67% | 36.36% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 99.995 | 1.43 | 0.010 | 1.44 | 1 | -2.05% | -14.37% | 41.58% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 0.017 | ― | ― | 1 | 0.00% | -10.53% | -29.17% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 1.82 | 0.020 | 1.84 | 1 | -8.08% | -44.68% | -87.14% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 0.01 | ― | ― | 1 | 11.11% | 11.11% | 11.11% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 3.75 | 0.020 | 3.77 | 1 | -5.78% | -34.44% | -75.95% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 312.45 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -75.00% | 9 Jul. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.